This paper considers the problem of comparing a new treatment with a control based on multiple endpoints. The hypotheses are formulated with the goal of showing that the treatment is equivalent, i.e. not inferior, on all endpoints and superior on at least one endpoint compared to the control, where thresholds for equivalence and superiority are specified for each endpoint. Roy's (1953) union-intersection and Berger's (1982) intersection-union principles are employed to derive the basic test. It is shown that the critical constants required for the union-intersection test of superiority can be sharpened by a careful analysis of its type I error rate. The composite - test is illustrated by an example and compared in a simulation study to alternative tests proposed by Bloch et al. (2001) and Perlman & Wu (2004). The Bloch et al. test does not control the type I error rate because of its nonmonotone nature, and is hence not recommended. The - and the Perlman & Wu tests both control the type I error rate, but the latter test generally has a slightly higher power.
I
Many clinical trials compare a treatment with a control on multiple endpoints. Often, the treatment is expected to have a positive effect on most, but not necessarily on all, endpoints. However, in order for the treatment to be preferred to the control, it may be sufficient to show that the treatment is not inferior, i.e. not much worse, on any of the endpoints and is strictly superior on at least one endpoint, or some specified number of endpoints. We formulate this as a combination of a union-intersection and an intersectionunion testing problem, and propose a test based on the corresponding testing principles. Bloch et al. (2001) considered a similar formulation to ours, but used Hotelling's T 2 statistic to test for superiority. Perlman & Wu (2004) suggested replacing the T 2 statistic 716 A C. T  B R. L in the Bloch et al. test with a one-sided likelihood ratio statistic. We compare both these tests with our proposed test via simulation.
P  
Consider a treatment group, group 1, and a control group, group 2, with n 1 and n 2 patients. Suppose that mÁ2 endpoints are measured on each patient. Denote the random data vectors from group i by X ij =(X ij1 , X ij2 , . . . , X ijm ), for i=1, 2 and j=1, 2, . . . , n i . We assume that the X ij are independent and identically distributed random vectors from an m-variate normal distribution with mean vector m i =(m i1 , m i2 , . . . , m im ) and a common unknown covariance matrix S={s kl } with s kk =s2 k =var (X ijk ) and s kl =cov (X ijk , X ijl ) for kNl. Denote the correlation matrix by R with off-diagonal entries r kl =corr (X ijk , X ijl )=s kl /s k s l . Let h k =m 1k −m 2k and let h=(h 1 , . . . , h k )=m 1 −m 2 be the vector of mean differences between the treatment and control.
The treatment is regarded as superior to the control on the kth endpoint if h k >d k and equivalent, i.e. non-inferior, to the control if h k >−e k , where the constants d k , e k Á0 are specified. Note that often d k =0 is used because most experimental treatments are expected to show only small improvements over the control which are nonetheless regarded as beneficial. The hypotheses for showing the superiority and equivalence of the treatment on the kth endpoint are as follows:
It is desired to test
at a preassigned level a. For m=2, the regions of the parameter space corresponding to H 0 and H 1 are shown in Fig. 1 . Note that (2·1) is a combination of union-intersection 3. T     Let X 9 1·k and X 9 2·k be the sample means for the kth endpoint for groups 1 and 2, respectively. Furthermore, let S2 1 , S2 2 , . . . , S2 m be the pooled sample variances based on n=n 1 +n 2 −2 degrees of freedom. We follow the usual convention of upper-case letters for random variables and the corresponding lower case letters for their observed values.
The pivotal random variable for h k is
Each T k is marginally distributed as t n . The joint distribution of (T 1 , T 2 , . . . , T m ) is the multivariate generalisation of a bivariate t-distribution considered by Siddiqui (1967) .
Since the joint distribution of (T 1 , T 2 , . . . , T m ) depends on the unknown correlation matrix R, the exact critical constants needed to compute simultaneous 100(1−a)% confidence intervals for the h k are not available. Based on the Bonferroni method, conservative lower one-sided confidence intervals are given by
where t n,a/m is the upper a/m critical point of the t n distribution. We reject H 0 if all L k >−e k and at least one L k >d k . Defining the t-statistics for testing the superiority and equivalence of the treatment on the kth endpoint by
we see that the above test reduces to min 1∏k∏m
In fact, since all inferences follow from a single set of simultaneous confidence bounds (3·2), all endpoints can be classified with 1−a confidence as follows: on the kth endpoint the treatment is not equivalent, i.e. inferior, if L k ∏−e k , is equivalent but not superior if −e k <L k ∏d k , and is superior if L k >d k . In the next section we show how the test (3·4) can be sharpened by applying the union-intersection and intersection-union principles of test construction.
A    -  - 
4·1. T he union-intersection and intersection-union, -, test An a-level test of (2·1) derived by applying the intersection-union principle is as follows: This - test is conservative because it requires that the type I error probability be separately controlled for H(E) 0 and H(S) 0 , which assumes the least favourable configuration that one of the two hypotheses is true and the other is infinitely false. It is possible to have H(E) 0 true and H(S) 0 infinitely false; for example, we can have h k =−e k and h l 2 for lNk. In fact, this is the least favourable configuration for the intersection-union test. However, we cannot have H(S) 0 true and H(E) 0 infinitely false because if h k ∏d k for all k then it cannot be simultaneously true that h l 2 for some l. This suggests that, although the critical constant t n,a for the intersection-union test of H(E) 0 cannot be reduced, it may be possible to reduce the critical constant t n,a/m for the union-intersection test of H(S) 0 . From now on, we will use a general notation, c and d, for the critical constants of H(E) 0 and H(S) 0 , respectively. In the next section we investigate how to find the smallest possible values of c and d.
4·2. Sharpened critical constants for the - test By using the relationship
we can write the - test as 
then H(S) 0 is automatically rejected; thus superiority need not be tested separately. We obtain an expression for the type I error probability of the - test (4·1) in Lemma 1, and then find its least favourable configuration in Lemma 2.
has an m-variate standard normal distribution with correlation matrix R independently of U=(U 1 , . . . , U m ). Denote the density functions of Z and U by w m (z|R) and h m,n (u|R), respectively. L et
T hen the probability that the - test (4·1) rejects H 0 of (2·1) can be written as
where
In the above, if d<c−(a k +b k )/u k for any u k Á0 (1∏k∏m) then the second integral is taken to be zero.
Proof. Write the desired probability as the difference between
Then, by conditioning on the U k , we can write the two probabilities as multivariate normal integrals shown in (4·5). The final expression (4·4) is obtained by removing the conditioning on U. % To simplify the notation, from now on, we will assume that S and R are known or equivalently that n 2. Therefore U k 1 for all k and Q(h) Y(h|u=1 m ) almost surely, where 1 m is an m-vector of ones.
L 2. T he type I error probability of the - test is maximised at one or more of the following configurations:
Thus, Q(h) is increasing in each h k and hence is maximised over H(S) 0 at  0 and over
The global maximum is found by evaluating Q(h) at each of these m+1 least favourable configurations, and taking the overall maximum.
%
Then for  0 we obtain a k =e k and b k =0, so that
For  k (1∏k∏m) we obtain a k =0, b k =−e k and a l , b l 2 for lNk, so that
. . .
=1−W(c). (4·9) T ests on multiple endpoints
Equating this to a, we obtain c=z a . For n<2, the above equation can be shown to be Proof. If e k 0 for all k then by substituting d=c in (4·8) we obtain
Therefore, the type I error probability is controlled below a. If e k 2 for all k then we obtain
by substituting d=z m,R,a . %
From the first result in Lemma 3 we see that it is possible to have d∏c for small e k . Note also that z a/m is the Bonferroni upper bound on z m,R,a .
4·3. Bootstrap implementation of the - test
The previous results show that, to apply the - test at level a, we must set c=t n,a and then solve for d by setting the finite degrees of freedom version of (4·8) equal to a; that is
where T 1 , T 2 , . . . , T m have the generalised multivariate t distribution referred to earlier. Evaluation of this probability requires the knowledge of S. To obviate this difficulty, we propose the following bootstrap algorithm. This algorithm does not directly compute d, but determines if max 1∏k∏m t(S) k >d or not, and hence whether H(S) 0 can be rejected or not. In conjunction with the test of H(E) 0 , this enables us to conduct the - test in (4·1). The algorithm is as follows.
Step 0. If min 1∏k∏m t(E) k ∏c=t n,a then accept H(E) 0 and hence H 0 and stop. Otherwise go to Step 1.
Step 1. Centre the observed data vectors x ij by subtracting the sample mean vector x : i· . Denote the centred data vectors by x* ij (i=1, 2; 1∏j∏n i ).
Step 2. Draw B bootstrap samples with replacement from the pooled sample of centred data vectors. Denote the bth bootstrap sample by x* ijb (i=1, 2; 1∏j∏n i ; 1∏b∏B).
Step 3. Calculate the statistics t*(E) kb and t*(S) kb for the bootstrap data using (3·3) for k=1, 2, . . . , m and b=1, 2, . . . , B.
Step 4. For the bth bootstrap sample, if min 1∏k∏m t*(E) kb >c=t n,a and max 1∏k∏m t*(S) kb > max 1∏k∏m t(S) k then reject H 0 ; otherwise accept H 0 . Repeat this for all B bootstrap samples.
Step 5. Let A be the number of bootstrap samples in which H 0 is rejected and let p @ =A/B be the corresponding proportion. If p @ <a then reject H(S) 0 and hence H 0 at level a.
The following points should be noted regarding the bootstrap implementation of the - test:
(i) the algorithm essentially sets d=max 1∏k∏m t(S) k and estimates the p-value for rejecting H(S) 0 conditional on having rejected H(E) 0 at level a; (ii) it does not explicitly make use of normality, other than using c=t n,a , and in this respect the algorithm is similar to the Bloch et al. (2001) algorithm; (iii) it can be readily modified to allow for heteroscedastic covariance matrices, in which case the t-statistics in (3·3) must be also modified to use separate variance estimates for the treatment and control groups.
E
We use an example from Tang et al. (1993) about the efficacy of an inhaled drug for asthma compared to placebo. Seventeen patients were randomised in a double-blind crossover trial. There were four standard respiratory function measures, i.e. endpoints, namely forced expiratory volume, , forced vital capacity, , peak expiratory flow rate, , and penetration index, . There was no period or crossover effect, so the comparisons for the individual endpoints could be performed using paired t-statistics. The summary statistics are shown in Table 1 and the estimated correlation matrix is
For these data, the ordinary least squares and generalised least squares statistics of O'Brien (1984) are highly significant indicating a global improvement. However, none of the individual endpoints can be shown to have significant improvement at a=0·05 using the Bonferroni method or one of its sharpened versions. Suppose d k =0 and e k =ls k with l=0·50 for 1∏k∏4. Then we have
ests on multiple endpoints
here √(1/n 1 +1/n 2 ) is replaced by √(1/n) since this is essentially a paired-sample study with n patients. The t-statistics given Table 1 {t(S) k +2·062}=min {3·744, 3·892, 3·172, 4·027}>c=1·746, so that H(E) 0 is rejected. We next apply the bootstrap algorithm of § 3 to test H(S) 0 , but, since only summary statistics are available for these data, we cannot directly apply the bootstrap algorithm since it is given for raw data. Instead, we applied a parametric version in which we drew samples from a four-variate normal distribution with a null mean vector and the estimated correlation matrix along with the sample standard deviations given in Table 1 . A total of 100 000 bootstrap samples were drawn and the estimated proportion of rejections of H(S) 0 was observed to be 0·04488. Therefore H 0 is rejected at the 5% level and the inhaled drug is shown to be preferred to the placebo.
T    6·1. T he Bloch, L ai & T ubert-Bitter (2001) test
Bloch et al. (2001) considered the superiority-equivalence formulation, for the special case of all d k =0, in a general nonparametric setting using a bootstrap approach similar to ours. To test H(S) 0 they employed a one-sided version of Hotelling's T 2 statistic, modified to allow for unequal covariance matrices, which equals T 2 if H(E) 0 is rejected and is zero otherwise. To test H(E) 0 in the normal setting, they used the same intersection-union test that we used, with rejection region min 1∏k∏m t(E) k >t n,a . If we denote the indicator function of an event A by I(A), their test rejects H 0 if
where d>0 is a critical constant that is determined via bootstrap to make the type I error rate equal to the specified level a under the null configuration. For the normal, homoscedastic setting of the present paper, we have
, and
is the pooled sample covariance matrix. It should be noted that the Bloch et al. test is non-monotone (Cohen & Sackrowitz, 1998) for certain choices of e k ; see Fig. 2 . Thus the type I error of the test in the interior of H(S) 0 : ]m k=1 h k ∏0 may exceed that at the null configuration, h k =0 for all k, which is the configuration used to determine the critical constant d, so that the test may become anti-conservative. Perlman & Wu (2004) (2001) test by the multivariate one-sided likelihood ratio statistic derived by Perlman (1969). Furthermore, they tested H(S) 0 and H(E) 0 separately at level a, the latter using the same intersection-union test as ours. Their test statistic for testing H(S) 0 is the difference between the observed vector x : 1· −x : 2· and its projection on to the nonpositive orthant O−={h|h k ∏0 for all k} with respect to the norm dxd2=x∞S C −1x. Denote this statistic by U2. Then the Perlman & Wu test rejects if U2>d, min 1∏k∏m
where d is the upper a critical constant for testing H(S) 0 and is the solution to the equation (Perlman, 1969)
In their simulation study, Perlman & Wu (2004) 
where T 2 m,n 1 +n 2 −m−1,a is the upper a critical constant of T 2. Note that this form of the Bloch et al. test as well as the Perlman & Wu test given in (6·2), which test H(S) 0 and H(E) 0 separately each at level a, are conservative. In our simulations, we used the original form (6·1) of the Bloch et al. test and we modified the Perlman & Wu test (6·2) to conform to the same form by evaluating its critical constant d via bootstrap so that the overall type I error probability is controlled at a.
S 
The simulation study was aimed at investigating the control of the type I error rate over the entire null space by the -, Perlman & Wu (2004) and Bloch et al. (2001) tests, as well as comparing their powers. Throughout, we used s2 First, we investigated the type I error rates for two types of null configuration, one where h k =0 for all k, that is all endpoints have a zero treatment effect, and the other where m/2 of the endpoints have a zero treatment effect and the remaining m/2 have a treatment effect equal to −l/2. We considered m=2, 4, 8, l=0·2, 0·5, 0·8, n 1 =n 2 =50 and an equicorrelated matrix with r=0·0, 0·5. The estimated type I error rates are given in Table 2 . Note that the Bloch et al. test has excessive type I error rates, as high as 0·244, when e k =l=0·8 and h is an m-vector of m/2 zeros followed by m/2 elements equal to T ests on multiple endpoints 2 0·2 0·0  0·052  0·052  0·052  0·024  0·024  0·024  0·5  0·050  0·050  0·049  0·026  0·027  0·027   0·5 0·0  0·052  0·052  0·052  0·014  0·011  0·013  0·5  0·050  0·049  0·050  0·022  0·020  0·035   0·8 0·0  0·048  0·048  0·050  0·014  0·011  0·109  0·5  0·047  0·047  0·049  0·025  0·023  0·211   4 0·2 0·0  0·004  0·004  0·004  0·001  0·001  0·001  0·5  0·047  0·047  0·047  0·023  0·023  0·023   0·5 0·0  0·053  0·049  0·049  0·007  0·004  0·005  0·5  0·049  0·049  0·048  0·018  0·018  0·032   0·8 0·0  0·053  0·051  0·050  0·009  0·005  0·101  0·5  0·047  0·048  0·052  0·026  0·024  0·228   8 0·2 0·0  0·000  0·000  0·000  0·000  0·000  0·000  0·5  0·020  0·020  0·020  0·008  0·008  0·008   0·5 0·0  0·047  0·045  0·046  0·001  0·001  0·001  0·5  0·051  0·050  0·053  0·018  0·017  0·032   0·8 0·0  0·048  0·046  0·046  0·004  0·001  0·060  0·5  0·049  0·047  0·050  0·025  0·024  0·244 For the right-hand columns, h is an m-vector of m/2 zeros and m/2 elements of −l/2. (Logan, 2003) .
Next we investigated the powers of the three procedures to detect treatment differences. The global powers to identify the treatment as non-inferior on all endpoints and superior on at least one endpoint were compared for the same scenarios as above, but for different treatment-effect configurations. The power results are given in Table 3 for l=0·5. Results for other values of l were similar with the differences in power among the tests increasing is mainly due to its inflated type I error rate. When comparing the - test with the Perlman & Wu test, we see that the former has slightly higher power in general when fewer than half of the endpoints have positive treatment effects, while the Perlman & Wu test has significantly higher power when half or more of the endpoints have positive treatment effects. This is consistent with the previous findings on superiority tests (Logan, 2003) . It is interesting to note that the power of the procedures is sensitive to the correlation in a specific pattern. When half or fewer of the endpoints have a nonzero treatment effect, the power is higher for correlated endpoints, but, when more than half have a nonzero treatment effect, the power is higher for uncorrelated endpoints.
Based on the simulation results, we conclude that the Perlman & Wu test has the best performance of the three tests. The - test is a close second. The Bloch et al. test has power comparable to the Perlman & Wu test, but it does not control the type I error rate and hence is not recommended.
All of the above tests address a single global hypothesis in (2·1). It might be useful to derive a stepwise multiple test procedure that can determine which of the endpoints show a superior treatment effect with familywise error rate control (Hochberg & Tamhane,
